Why the study?
Cardiogenic shock remains a deadly disease that rapidly causes hypoperfusion and end-organ dysfunction, with scalable heterogeneity in hemodynamic-based management across healthcare systems.
This review highlights the need for systematic, hemodynamic-based management and an adaptive situational awareness model to improve early identification and care transitions in cardiogenic shock.
Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometabolic clinical catastrophe. Based on the scalable heterogeneity from a cellular level to healthcare systems in the hemodynamic-based management of patients experiencing CS, the authors present considerations towards systematic hemodynamic-based transitions in which distinct clinical entities share the common path of early identification and rapid transitions through an adaptive longitudinal situational awareness model of care that influences specific management considerations. Future studies are needed to best understand optimal management of drugs and devices along with engagement of health systems of care for patients with CS.
No takes yet. Share an insight, caveat, or question.
Hernández-Montfort et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: